Use of Oral Ribavirin for the Treatment of RSV Infections in Hematopoietic Cell Transplant (HCT) Recipients

BACKGROUND: The benefit of aerosolized ribavirin (AR) in reducing the risk of progression of RSV infections and RSV-associated mortality in HCT recipients has been recognized, yet there is a paucity of data assessing the use of oral ribavirin (OR) in this patient population. We evaluated outcomes as...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Open Forum Infect Dis
Auteurs principaux: Foolad, Farnaz, Aitken, Samuel L, Prayag, Amrita, Ghantoji, Shashank S, Ariza-Heredia, Ella, Shah, Dimpy P, Chemaly, Roy
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2017
Sujets:
Abstracts
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7107211/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofx163.1358
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires